Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Splicing alterations in healthy aging and disease

Wiley Interdisciplinary Reviews - RNA(2021)10.1002/wrna.1643Source: DataRank Database

Splicing alterations in healthy aging and disease is a research paper published in Wiley Interdisciplinary Reviews - RNA (2021). On theSindex it has a DataRank of 0. It has been cited 76 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access76 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: greenTopics (11)Linked Datasets (12)DataCite Reuse (12)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Olga Anczuków ORCID,Brittany Angarola ORCID

Live enrichment

PubMed:33565261 PMC:PMC8195850

National Institutes of Health

Grant: T32AG062409A, P30CA034196

V Foundation for Cancer Research

Grant: V2018‐018

NIA NIH HHS

Grant: T32 AG062409

NCI NIH HHS

Grant: P30 CA034196

Jackson Laboratory

greenLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8195850

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/wrna.1643

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/wrna.1643

publisherhttps://wires.onlinelibrary.wiley.com/doi/pdf/10.1002/wrna.1643

MeSH Terms

SpliceosomesHumansProteomicsRNA SplicingAlternative SplicingHealthy Aging

Keywords

RNAAgingDiseaseAlternative splicingSplicing Factors

Additional file 1 of Nuclear speckle specific hnRNP D-like prevents age- and AD-related cognitive decline by modulating RNA splicing

10.6084/m9.figshare.16664627.v1figshare

Additional file 1 of Nuclear speckle specific hnRNP D-like prevents age- and AD-related cognitive decline by modulating RNA splicing

10.6084/m9.figshare.16664627figshare

Additional file 2 of Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer

10.6084/m9.figshare.25303133.v1figshare

Additional file 2 of Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer

10.6084/m9.figshare.25303133figshare

Additional file 5 of Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer

10.6084/m9.figshare.26685852figshare

Additional file 3 of Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer

10.6084/m9.figshare.26685846.v1figshare

Additional file 5 of Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer

10.6084/m9.figshare.26685852.v1figshare

Additional file 3 of Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer

10.6084/m9.figshare.26685846figshare

Additional file 4 of Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer

10.6084/m9.figshare.26685849.v1figshare

Additional file 4 of Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer

10.6084/m9.figshare.26685849figshare

Additional file 1 of Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer

10.6084/m9.figshare.25302963.v1figshare

Additional file 1 of Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer

10.6084/m9.figshare.25302963figshare

Related Papers (9)

The RNA-binding protein AKAP8 suppresses tumor metastasis by antagonizing EMT-associated alternative splicing

Nature Communications(2020)

OpenAlex related

10.1038/s41467-020-14304-1

Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis

Oncogene(1999)

OpenAlex related

10.1038/sj.onc.1202671

An overview of RNA splicing and functioning of splicing factors in land plant chloroplasts

RNA Biology(2022)

OpenAlex related

10.1080/15476286.2022.2096801

Neuron-specific splicing

BioScience Trends(2016)

OpenAlex related

10.5582/bst.2016.01169

Evidence for the function of an exonic splicing enhancer after the first catalytic step of pre-mRNA splicing

Proceedings of the National Academy of Sciences(1999)

OpenAlex related

10.1073/pnas.96.19.10655

Regulation of alternative splicing within the supraspliceosome

Journal of Structural Biology(2011)

OpenAlex related

10.1016/j.jsb.2011.11.005

Half Pint/Puf68 is required for negative regulation of splicing by the SR factor Transformer2

RNA Biology(2013)

OpenAlex related

10.4161/rna.25645

General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer.

Genes & Development(1993)

OpenAlex related

10.1101/gad.7.12b.2598

Pre-mRNA Splicing Mechanisms, Misregulation in Disease, and Therapeutic Strategies

Blood(2012)

OpenAlex related

10.1182/blood.v120.21.sci-13.sci-13